[1] Molina R,Augé JM,Bosch X, et al. Usefulness of serum tumor markers,including progastrin-releasing peptide,in patients with lung cancer: correlation with histology[J].Tumour Biol,2013,30 (3) :121-129.
[2] Pinson P,Joos G,Watripont P,et al. Serum neuron-specific enolaseas a tumor marker in the diagnosis and follow-up of small-cell lung cancer[J].Respiration,2013,64(1):102-107.
[3] 李海燕,刘红,王静,等. 肿瘤标志物联合检测在肺癌诊断中的价值[J].中国老年学杂志,2013,32(1):46-48.
[4] 张宝秋,丁湘彧,王雪玉,等.肿瘤标志物联合检测在肺癌诊断中的应用价值[J].国际检验医学杂志,2013,33(4) : 388-390.
[5] 刘军,张树重.常见血清肿瘤标志物及其联合检测对肺癌辅助诊断现状分析[J].中国美容医学,2013,21(z1):71-72.
[6] 阎飞,张定昌.血清肿瘤标记物联合检测诊断肺癌的临床价值[J].山东医药,2013,51(19):67-68.
[7] 杜红心,罗海峰,彭必江,等.联合检测CEA、NSE和CYFRA21-1在肺癌诊断中的价值[J].国际检验医学杂志,2013,31(5):447-448.
[8] 张树才,马玙,杨新杰,等.血清糖链抗原CA242与其他肺癌标志物联合检测对肺癌的诊断价值[J].中华结核和呼吸杂志,2013,22(5):271.
[9] 李毅星.血清肿瘤标记物联合检测在肺癌诊断中的应用价值[J].中国煤炭工业医学杂志,2013,14(1):72-73.
[10] Alatas F,Alatas O,Metintas M,et al.Diagnostic value of CEA,CA15-3,CA19-9,CYFRA21-1,NSE and TSA assay in pleural effusions[J].Lung Cancer,2013,31(1):9-16.
[11] Shitrit D,Zingerman B,Shitrit AB,et al.Diagnostic value ofCRFRA21-1,CEA,CA19-9,CA15-3,and CA125 assays in pleuraleffusions: analysis of 116 cases and review of the literature[J].Oncologist,2013,10(7):501-507.
[12] 廖君群. 胸腔积液CEA、CA19-9、CYFRA21-1、AFP 和FERR在肺癌诊断中的价值[J].国际检验医学杂志,2013,34(10):1216. |
2020, Vol. 37 
